2010美国内分泌学会指南：类固醇21- 羟化酶缺乏引起的先天性肾上腺增生症

中文标题：

2010美国内分泌学会指南：类固醇21- 羟化酶缺乏引起的先天性肾上腺增生症

英文标题：

Congenital Adrenal Hyperplasia Due Congenital Adrenal Hyperplasia Due to Steroid 21-hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

发布机构：

美国内分泌学会

发布日期：

2010-01-01

简要介绍：

Authors: Phyllis W. Speiser, Ricardo Azziz, Laurence S. Baskin, Lucia Ghizzoni, Terry W. Hensle, Deborah P.Merke, Heino F. L. Meyer-Bahlburg, Walter L. Miller, Victor M. Montori, Sharon E. Oberfield, Martin Ritzen, andPerrin C. White Co-Sponsoring Associations: American Academy of Pediatrics, Androgen Excess and PCOS Society, CARESFoundation, European Society of Endocrinology, European Society for Paediatric Endocrinology, Pediatric Endocrine Society, and the Society of Pediatric Urology.Affiliations: Cohen Children’s Medical Center of New York and Hofstra University School of Medicine (P.W.S.),New Hyde Park, New York 11040; Cedars-Sinai Medical Center (R.A.), Los Angeles, California 90048; University of California San Francisco (L.S.B., W.L.M.), San Francisco, California 94143; University of Turin (L.G.), 10129 Turin, Italy; Columbia University (T.W.H.), New York, New York 10032; National Institutes of Health Clinical Center and The Eunice Kennedy Shriver National Institute of Child Health and Human Development (D.P.M.),Bethesda, Maryland 20892; New York State Psychiatric Institute/Columbia University (H.F.L.M.-B.) and Children’s Hospital of New York-Presbyterian and Columbia University College of Physicians & Surgeons (S.E.O.), New York, New York 10032; Mayo Clinic (V.M.M.), Rochester, Minnesota 55905; Karolinska Institute (M.R.), 17176 Stockholm, Sweden; and University of Texas Southwestern Medical Center (P.C.W.), Dallas, Texas 75390 Disclaimer: Clinical Practice Guidelines are developed to be of assistance to endocrinologists and other health care professionals by providing guidance and recommendations for particular areas of practice. The Guidelines should not be considered inclusive of all proper approaches or methods, or exclusive of others. The Guidelines cannot guarantee any specific outcome, nor do they establish a standard of care. The Guidelines are not intendedto dictate the treatment of a particular patient. Treatment decisions must be made based on the independent judgmentof health care providers and each patient’s individual circumstances. The Endocrine Society makes no warranty, express or implied, regarding the Guidelines and specifically excludesany warranties of merchantability and fitness for a particular use or purpose. The Society shall not be liable fordirect, indirect, special, incidental, or consequential damages related to the use of the information contained herein.